Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical Utility of Cell-free and Circulating Tumor DNA in Kidney and Bladder Cancer: A Critical Review of Current Literature

8 May 2021

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Cancer Cells and Metastasis
Share to Cancer Genomics and Diagnostics

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33975782
DOI: 10.1016/j.euo.2021.04.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical Utility of Cell-free and Circulating Tumor DNA in Kidney and Bladder Cancer: A Critical Review of Current LiteraturePMID 33975782Read ↗

Cell-free DNA in the blood as a solid tumor biomarker—A critical appraisal of the literatureSemantic proximity Read ↗

Detecting circulating tumor DNA in renal cancer: An open challengeSemantic proximity Read ↗

Monitoring tumor-derived cell-free DNA in patients with solid tumors: Clinical perspectives and research opportunitiesSemantic proximity Read ↗

Role of Circulating Cell-Free DNA in CancersSemantic proximity Read ↗

Diagnostic and prognostic potential of circulating cell-free genomic and mitochondrial DNA fragments in clear cell renal cell carcinoma patientsSemantic proximity Read ↗

Circulating Tumor DNA as Biomarkers for Cancer DetectionSemantic proximity Read ↗

Revolution of Circulating Tumor DNA: From Bench Innovations to Bedside ImplementationsSemantic proximity Read ↗

Circulating cell-free DNA for non-invasive cancer managementSemantic proximity Read ↗

Next-generation sequencing (NGS) of cell-free circulating tumor DNA and tumor tissue in patients with advanced urothelial cancer: a pilot assessment of concordanceSemantic proximity Read ↗

Clinical Practice Guideline for Blood-based Circulating Tumor DNA Assays.Semantic proximity Read ↗

Cancer DNA in the CirculationSemantic proximity Read ↗

Cell-free circulating tumor DNA profiling in cancer managementSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.